HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Haleon Starts Standalone Life By Raising Sales Expectations

Executive Summary

A better than expected first-half performance has put Haleon on a sure footing for the rest of the year following its recent demerger from GSK.

You may also be interested in...

GSK Exits Consumer Health With Haleon Launch

The global market leader in consumer health is now Haleon following its separation from GSK after more than two years of planning.

Euro Q2 Consumer Health Earnings Preview: Volatility, Delay, Upturn And Goodbye

Major Europe-based consumer health players Bayer, Sanofi, Reckitt and GSK feature in this sales and earnings preview, which highlights what to look out for as these four firms report their Q2 2022 results over the coming weeks.

GSK Achieves Strong Sales Growth In Q1 Despite Cost Of Living Pressures On Consumers

GSK Consumer Healthcare's CEO Brian McNamara said he had not seen signs that the cost of living crisis was impacting consumer purchases, with sales at the business up 16% in Q1.

Related Content


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts